Placemark Investments’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Placemark Investments’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$5.91M	Buy	102,833 +4,999	+5%	+$279K	0.1%	246
2014 Q3	$5.26M	Buy	97,834 +35,209	+56%	+$1.87M	0.1%	258
2014 Q2	$3.28M	Buy	62,625 +13,333	+27%	+$681K	0.06%	391
2014 Q1	$2.6M	Sell	49,292 -5,436	-10%	-$251K	0.05%	440
2013 Q4	$2.19M	Buy	54,728 +15,694	+40%	+$618K	0.04%	527
2013 Q3	$1.47M	Sell	39,034 -9,632	-20%	-$376K	0.03%	633
2013 Q2	$1.91M	Buy	+48,666	New	+$1.9M	0.04%	505

Other funds holding TEVA

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Placemark Investments's TEVA Position: Q4 2014 in Review

Placemark Investments increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 5.1% in Q4 2014, buying an estimated $279K and bringing the position to 102,833 shares worth $5.91M. The position accounts for 0.1% of the portfolio, ranked #246.

Placemark Investments first reported a position in TEVA in Q2 2013 and has held it in 7 quarters since. 822 funds tracked by Wall St. Rank hold TEVA as of Q4 2014.

Placemark Investments held 102,833 shares of Teva Pharmaceutical Industries Limited worth $5.91M as of Q4 2014.
Placemark Investments bought 4,999 Teva Pharmaceutical Industries Limited shares in Q4 2014, an estimated $279K.
Teva Pharmaceutical Industries Limited made up 0.1% of Placemark Investments's portfolio in Q4 2014, its #246 holding.
Placemark Investments first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 7 quarters since.
822 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.